1 |
DI NOIA J M, NEUBERGER M S. Molecular mechanisms of antibody somatic hypermutation[J]. Annu Rev Biochem, 2007, 76: 1-22.
|
2 |
MURAMATSU M, KINOSHITA K, FAGARASAN S, et al. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme[J]. Cell, 2000, 102(5): 553-563.
|
3 |
YEAP L S, HWANG J K, DU Z, et al. Sequence-intrinsic mechanisms that target AID mutational outcomes on antibody genes[J]. Cell, 2015, 163(5): 1124-1137.
|
4 |
HAYNES B F, MOODY M A, LIAO H X, et al. B cell responses to HIV-1 infection and vaccination: pathways to preventing infection[J]. Trends Mol Med, 2011, 17(2): 108-116.
|
5 |
KWONG P D, MASCOLA J R. Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies[J]. Immunity, 2012, 37(3): 412-425.
|
6 |
WALKER L M, PHOGAT S K, CHAN-HUI P Y, et al. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target[J]. Science, 2009, 326(5950): 285-289.
|
7 |
KEPLER T B, LIAO H X, ALAM S M, et al. Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodies[J]. Cell Host Microbe, 2014, 16(3): 304-313.
|
8 |
YU L, GUAN Y J. Immunologic basis for long HCDR3s in broadly neutralizing antibodies against HIV-1[J]. Front Immunol, 2014, 5: 250.
|
9 |
METHOT S P, DI NOIA J M. Molecular mechanisms of somatic hypermutation and class switch recombination[M]//Advances in Immunology. Amsterdam: Elsevier, 2017: 37-87.
|
10 |
ZANOTTI K J, GEARHART P J. Antibody diversification caused by disrupted mismatch repair and promiscuous DNA polymerases[J]. DNA Repair (Amst), 2016, 38: 110-116.
|
11 |
BENNETT S E, SUNG J S, MOSBAUGH D W. Fidelity of uracil-initiated base excision DNA repair in DNA polymerase β-proficient and -deficient mouse embryonic fibroblast cell extracts[J]. J Biol Chem, 2001, 276(45): 42588-42600.
|
12 |
GU H, MARTH J D, ORBAN P C, et al. Deletion of a DNA polymerase β gene segment in T cells using cell type-specific gene targeting[J]. Science, 1994, 265(5168): 103-106.
|
13 |
NIU J Y, XIONG J, HU D, et al. 2', 3'-dideoxycytidine protects dopaminergic neurons in a mouse model of Parkinson's disease[J]. Neurochem Res, 2017, 42(10): 2996-3004.
|
14 |
MERLO S, BASILE L, GIUFFRIDA M L, et al. Identification of 5-methoxyflavone as a novel DNA polymerase-beta inhibitor and neuroprotective agent against β-amyloid toxicity[J]. J Nat Prod, 2015, 78(11): 2704-2711.
|
15 |
KIM A, HAN L, YU K F. Immunoglobulin class switch recombination is initiated by rare cytosine deamination events at switch regions[J]. Mol Cell Biol, 2020, 40(16): e00125-e00120.
|
16 |
STOCKDALE A M, DUL J L, WIEST D L, et al. The expression of membrane and secreted immunoglobulin during the in vitro differentiation of the murine B cell lymphoma CH12[J]. J Immunol, 1987, 139(10): 3527-3535.
|
17 |
YANG D P, SUN Y, CHEN J J, et al. REV7 is required for processing AID initiated DNA lesions in activated B cells[J]. Nat Commun, 2020, 11(1): 2812.
|
18 |
LANGMEAD B, SALZBERG S L. Fast gapped-read alignment with Bowtie 2[J]. Nat Methods, 2012, 9(4): 357-359.
|
19 |
ROBERT P A, MARSCHALL A L, MEYER-HERMANN M. Induction of broadly neutralizing antibodies in Germinal Centre simulations[J]. Curr Opin Biotechnol, 2018, 51: 137-145.
|
20 |
SCHEID J F, MOUQUET H, UEBERHEIDE B, et al. Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding[J]. Science, 2011, 333(6049): 1633-1637.
|
21 |
WU X L, YANG Z Y, LI Y X, et al. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1[J]. Science, 2010, 329(5993): 856-861.
|
22 |
CORTI D, CAMERONI E, GUARINO B, et al. Tackling influenza with broadly neutralizing antibodies[J]. Curr Opin Virol, 2017, 24: 60-69.
|
23 |
MURIRA A, LAPIERRE P, LAMARRE A. Evolution of the humoral response during HCV infection: theories on the origin of broadly neutralizing antibodies and implications for vaccine design[J]. Adv Immunol, 2016, 129: 55-107.
|
24 |
GILCHUK P, KUZMINA N, ILINYKH P A, et al. Multifunctional pan-Ebolavirus antibody recognizes a site of broad vulnerability on the Ebolavirus glycoprotein[J]. Immunity, 2018, 49(2): 363-374.e10.
|
25 |
ROBBIANI D F, BOZZACCO L, KEEFFE J R, et al. Recurrent potent human neutralizing antibodies to Zika virus in Brazil and Mexico[J]. Cell, 2017, 169(4): 597-609.e11.
|
26 |
TAN J, PIEPER K, PICCOLI L, et al. A LAIR1 insertion generates broadly reactive antibodies against malaria variant antigens[J]. Nature, 2016, 529(7584): 105-109.
|